Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes

C. Frati, C. Marchese, G. Fisichella, A. Copani, M. R. Nasca, M. Storto, F. Nicoletti

Research output: Contribution to journalArticle

Abstract

Cultured human melanocytes express mGlu5 metabotropic glutamate (mGlu) receptors, as shown by RT-PCR, immunocytochemistry, Western blot analysis, and measurement of agonist-stimulated polyphosphoinositide hydrolysis. The mGlu5 receptor agonists (S)-3,5-dihydroxyphenylglycine and quisqualate increased [3H-methyl]thymidine incorporation and melanocyte proliferation in subconfluent cultures, but impaired cell viability in confluent cultures. Both effects were prevented by 2-methyl-6-(2-phenyl-1-ethynyl)-pyridine, a potent and highly selective mGlu5 receptor antagonist. Agonists of other mGlu receptor subtypes (such as the mGlu2/3 receptor agonist, 2S,2'R,3'R-2-2',3'- dicarboxycyclopropylglycine, or the mGlu4/6/7/8 receptor agonist, L-2-amino- 4-phosphonobutanoate) or selective agonists of ionotropic glutamate receptors (N-methyl-D-aspartate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate, and kainate) did not affect melanocyte proliferation or viability. The presence of a receptor for glutamate, the major excitatory neurotransmitter, in human melanocytes is intriguing, mGlu5 receptors may be involved in the control of melanocyte proliferation (and perhaps in other functions), but harbor a potential toxicity and may therefore contribute to cell damage under pathological conditions. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)364-372
Number of pages9
JournalJournal of Cellular Physiology
Volume183
Issue number3
DOIs
Publication statusPublished - 2000

Fingerprint

Metabotropic Glutamate Receptors
Melanocytes
Cell culture
Cells
Quisqualic Acid
Ionotropic Glutamate Receptors
Phosphatidylinositol Phosphates
Kainic Acid
Glutamate Receptors
N-Methylaspartate
Ports and harbors
Thymidine
Neurotransmitter Agents
Toxicity
Hydrolysis
Cell Survival
Western Blotting
Immunohistochemistry
Polymerase Chain Reaction
pyridine

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. / Frati, C.; Marchese, C.; Fisichella, G.; Copani, A.; Nasca, M. R.; Storto, M.; Nicoletti, F.

In: Journal of Cellular Physiology, Vol. 183, No. 3, 2000, p. 364-372.

Research output: Contribution to journalArticle

Frati, C. ; Marchese, C. ; Fisichella, G. ; Copani, A. ; Nasca, M. R. ; Storto, M. ; Nicoletti, F. / Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. In: Journal of Cellular Physiology. 2000 ; Vol. 183, No. 3. pp. 364-372.
@article{acb8a5d339494a2c8c49448284e2ec16,
title = "Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes",
abstract = "Cultured human melanocytes express mGlu5 metabotropic glutamate (mGlu) receptors, as shown by RT-PCR, immunocytochemistry, Western blot analysis, and measurement of agonist-stimulated polyphosphoinositide hydrolysis. The mGlu5 receptor agonists (S)-3,5-dihydroxyphenylglycine and quisqualate increased [3H-methyl]thymidine incorporation and melanocyte proliferation in subconfluent cultures, but impaired cell viability in confluent cultures. Both effects were prevented by 2-methyl-6-(2-phenyl-1-ethynyl)-pyridine, a potent and highly selective mGlu5 receptor antagonist. Agonists of other mGlu receptor subtypes (such as the mGlu2/3 receptor agonist, 2S,2'R,3'R-2-2',3'- dicarboxycyclopropylglycine, or the mGlu4/6/7/8 receptor agonist, L-2-amino- 4-phosphonobutanoate) or selective agonists of ionotropic glutamate receptors (N-methyl-D-aspartate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate, and kainate) did not affect melanocyte proliferation or viability. The presence of a receptor for glutamate, the major excitatory neurotransmitter, in human melanocytes is intriguing, mGlu5 receptors may be involved in the control of melanocyte proliferation (and perhaps in other functions), but harbor a potential toxicity and may therefore contribute to cell damage under pathological conditions. (C) 2000 Wiley-Liss, Inc.",
author = "C. Frati and C. Marchese and G. Fisichella and A. Copani and Nasca, {M. R.} and M. Storto and F. Nicoletti",
year = "2000",
doi = "10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.0.CO;2-X",
language = "English",
volume = "183",
pages = "364--372",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes

AU - Frati, C.

AU - Marchese, C.

AU - Fisichella, G.

AU - Copani, A.

AU - Nasca, M. R.

AU - Storto, M.

AU - Nicoletti, F.

PY - 2000

Y1 - 2000

N2 - Cultured human melanocytes express mGlu5 metabotropic glutamate (mGlu) receptors, as shown by RT-PCR, immunocytochemistry, Western blot analysis, and measurement of agonist-stimulated polyphosphoinositide hydrolysis. The mGlu5 receptor agonists (S)-3,5-dihydroxyphenylglycine and quisqualate increased [3H-methyl]thymidine incorporation and melanocyte proliferation in subconfluent cultures, but impaired cell viability in confluent cultures. Both effects were prevented by 2-methyl-6-(2-phenyl-1-ethynyl)-pyridine, a potent and highly selective mGlu5 receptor antagonist. Agonists of other mGlu receptor subtypes (such as the mGlu2/3 receptor agonist, 2S,2'R,3'R-2-2',3'- dicarboxycyclopropylglycine, or the mGlu4/6/7/8 receptor agonist, L-2-amino- 4-phosphonobutanoate) or selective agonists of ionotropic glutamate receptors (N-methyl-D-aspartate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate, and kainate) did not affect melanocyte proliferation or viability. The presence of a receptor for glutamate, the major excitatory neurotransmitter, in human melanocytes is intriguing, mGlu5 receptors may be involved in the control of melanocyte proliferation (and perhaps in other functions), but harbor a potential toxicity and may therefore contribute to cell damage under pathological conditions. (C) 2000 Wiley-Liss, Inc.

AB - Cultured human melanocytes express mGlu5 metabotropic glutamate (mGlu) receptors, as shown by RT-PCR, immunocytochemistry, Western blot analysis, and measurement of agonist-stimulated polyphosphoinositide hydrolysis. The mGlu5 receptor agonists (S)-3,5-dihydroxyphenylglycine and quisqualate increased [3H-methyl]thymidine incorporation and melanocyte proliferation in subconfluent cultures, but impaired cell viability in confluent cultures. Both effects were prevented by 2-methyl-6-(2-phenyl-1-ethynyl)-pyridine, a potent and highly selective mGlu5 receptor antagonist. Agonists of other mGlu receptor subtypes (such as the mGlu2/3 receptor agonist, 2S,2'R,3'R-2-2',3'- dicarboxycyclopropylglycine, or the mGlu4/6/7/8 receptor agonist, L-2-amino- 4-phosphonobutanoate) or selective agonists of ionotropic glutamate receptors (N-methyl-D-aspartate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate, and kainate) did not affect melanocyte proliferation or viability. The presence of a receptor for glutamate, the major excitatory neurotransmitter, in human melanocytes is intriguing, mGlu5 receptors may be involved in the control of melanocyte proliferation (and perhaps in other functions), but harbor a potential toxicity and may therefore contribute to cell damage under pathological conditions. (C) 2000 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034057273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034057273&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.0.CO;2-X

DO - 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.0.CO;2-X

M3 - Article

C2 - 10797311

AN - SCOPUS:0034057273

VL - 183

SP - 364

EP - 372

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 3

ER -